We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.



Particles, whether visible or sub-visible, in a drug product are a very serious concern (e.g., obstruction of blood vessels, inducement of immunogenicity). Particles may result from external sources (e.g., dust), manufacturing (e.g., silicone oil), or interaction with the container/delivery systems (protein aggregates). This section presents papers on particle measurement, management and resultant effects.

Register below for access to our Online Technical Repository and for current customers, our Online Technical Customer Support Portal.

Non-Customer Content

Customer Content


NovaPure® is a registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.